Results 111 to 120 of about 6,122,672 (198)

Pseudoprogression During Enfortumab Vedotin Plus Pembrolizumab Therapy in Muscle‐Invasive Bladder Cancer Achieving Pathological Complete Response: A Case Report

open access: yesIJU Case Reports, Volume 9, Issue 6, November 2026.
ABSTRACT Introduction Enfortumab vedotin plus pembrolizumab has emerged as a standard first‐line therapy for advanced urothelial carcinoma (UC). However, pseudoprogression during this combination remains poorly characterized. Case Presentation A 71‐year‐old man with muscle‐invasive bladder cancer and lymph node metastasis received enfortumab vedotin ...
Yosuke Nakanishi   +9 more
wiley   +1 more source

Investigational agents in metastatic basal cell carcinoma: focus on vismodegib

open access: yes, 2012
Nicolas Batty,1 Ellen Kossoff,2 Grace K Dy11Department of Medicine, Roswell Park Cancer Center, Buffalo, NY, USA; 2Department of Pharmacy, Roswell Park Cancer Center, Buffalo, NY, USAAbstract: Vismodegib (GDC-0449, 2-chloro-N-(4-chloro-3-(pyridin-2-yl ...
Batty N, Kossoff E, Dy GK
core  

Desempenho dos marcadores EGFR, CK5, CK14, p63 e P-caderina para identificar o fenótipo basal do carcinoma de mama [PDF]

open access: yes, 2007
Dissertação (mestrado) - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde. Programa de Pós-Graduação em Ciências MédicasOs estudos dos perfis de expressão gênica dos carcinomas de mama identificaram um subtipo de tumor com pior ...
Vieira, Daniella Serafin Couto
core  

Lymph Node Regression Improves Prognostic Stratification in Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Chemoimmunotherapy: A Multicenter Retrospective Cohort Study

open access: yesMedComm, Volume 7, Issue 11, November 2026.
Pathological lymph node regression grading predicts survival after neoadjuvant chemoimmunotherapy. (A) Schematic illustration of the novel five‐tier lymph node regression grading (LNRG) system and representative histopathological images. LNRG 1–4 were defined as follows: LNRG 1, no viable tumor cells observed within the tumor bed; LNRG 2, viable tumor ...
Jian Zheng   +15 more
wiley   +1 more source

Clinical Features and Outcomes of Locally Advanced and Metastatic Basal Cell Carcinoma

open access: yesActa Dermato-Venereologica
Cutaneous basal cell carcinoma (BCC) is a primarily indolent tumour that is easily cured. However, locally advanced BCC (laBCC) and metastatic BCC can have a poor prognosis.
Anna A.J.H. Zwanenburg   +5 more
doaj   +1 more source

Metastatic insidious super giant basal cell carcinoma. [PDF]

open access: yesBMJ Case Rep, 2022
Ahmed M   +3 more
europepmc   +1 more source

Inflammatory Pseudotumour in Common Seal (Phoca vitulina): A Case Report

open access: yesVeterinary Medicine and Science, Volume 12, Issue 6, November 2026.
A 19‐year‐old intact male common seal (Phoca vitulina) diagnosed with a chronic ulcer. Microbiology identified Vibrio alginolyticus. Radiography noted phalanx alterations. Macroscopic, histopathological, and immunohistochemical examinations revealed a neoplastic origin with a myofibroblastic phenotype. This report describes the first documented case of
Javier M. De Pablo‐Moreno   +7 more
wiley   +1 more source

Delayed Diagnosis: Giant Basal Cell Carcinoma of Scalp

open access: yes, 2008
Although basal cell carcinoma (BCC) is the most common form of skin cancer, the scalp lesions of BCC have been rarely reported. Giant BCC is defined as a tumor larger than 5 cm in diameter and only 0.5-1% of all BCCs achieve this size.
Hakverdi, Sibel   +2 more
core  

What Is Your Diagnosis? Abnormal WNR Scattergram From the Sysmex XN‐1000V in a Dog

open access: yes
Veterinary Clinical Pathology, EarlyView.
Javier Martínez‐Caro   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy